Loading comparison data...
Compare Lecanemab (Leqembi) and RIVASTIGMINE (Exelon) — clinical data, side effects, and patient experiences.
Leqembi · Anti-Amyloid Antibody
How it works
Humanized monoclonal antibody targeting soluble amyloid-beta protofibrils, reducing amyloid plaque burden in early Alzheimer's.
Approved for
Exelon · Cholinesterase Inhibitor
How it works
12.1 Mechanism of Action Although the precise mechanism of action of rivastigmine is unknown, it is thought to exert its therapeutic effect by enhancing cholinergic function. This ...
Approved for
Estimated frequency (%) based on clinical trial data
No specific warnings
Based on 4 Reddit discussions
Lecanemab
50%
positive
4 threads
RIVASTIGMINE
0%
positive
0 threads
% of discussions mentioning each side effect
4 Reddit threads analysed for Lecanemab
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
44 upvotes
Most discussed side effects in community
👉 **TL;DR: This post is just the long—really long—and winding rant of a guy with a dog.** **Avoid reading this and go enjoy your life doing something else instead.** ​ **LCID starts to move.** Today, LCID started to move at 12:20 EST. Twenty-three minutes later, the reason surfaced:
**This is a re-post from my blog.** My first Lecanemab infusion was October 28, 2025. My tenth was February 17, 2026. The most frustrating part of Lecanemab treatment is not knowing if it is helping me. Is Lecanemab slowing the progression of my Alzheimer’s disease? I have no idea, and neither does
I published the following to my blog today: Last week, at the 2026 International Conference on Alzheimer's and Parkinson's Diseases, Eisai presented new real-world findings on the long-term usage of Lecanemab. Analyzing data from the [PurpleLab claims database](https://info.purplelab.com/clear-claim
Can someone convince me that Leqembi is actually a significant advancement in Alzheimer’s treatment? I admit to my ignorance in pharmacology, and I haven’t seen any legitimate articles on the drug. Therefore I’m trying to be very open minded if someone gives me an educated response. To me, Leqembi
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for RIVASTIGMINE yet.
Lecanemab is a Anti-Amyloid Antibody, while RIVASTIGMINE belongs to the Cholinesterase Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. Lecanemab is administered via Oral, whereas RIVASTIGMINE uses Transdermal. Route of administration can affect onset of action and patient adherence.
RIVASTIGMINE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.
Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.